These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 18227483)

  • 1. Does increased oxidative stress cause hypertension?
    Grossman E
    Diabetes Care; 2008 Feb; 31 Suppl 2():S185-9. PubMed ID: 18227483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertension and oxidative stress.
    Ward NC; Croft KD
    Clin Exp Pharmacol Physiol; 2006 Sep; 33(9):872-6. PubMed ID: 16922824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible role of oxidative stress in the pathogenesis of hypertension.
    Ceriello A
    Diabetes Care; 2008 Feb; 31 Suppl 2():S181-4. PubMed ID: 18227482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactive oxygen species and vascular biology: implications in human hypertension.
    Touyz RM; Briones AM
    Hypertens Res; 2011 Jan; 34(1):5-14. PubMed ID: 20981034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antioxidant treatment reduces matrix metalloproteinase-2-induced vascular changes in renovascular hypertension.
    Castro MM; Rizzi E; Rodrigues GJ; Ceron CS; Bendhack LM; Gerlach RF; Tanus-Santos JE
    Free Radic Biol Med; 2009 May; 46(9):1298-307. PubMed ID: 19248829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanisms of hypertension--reactive oxygen species and antioxidants: a basic science update for the clinician.
    Montezano AC; Touyz RM
    Can J Cardiol; 2012 May; 28(3):288-95. PubMed ID: 22445098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of tempol on endothelium-dependent vasodilatation and blood pressure.
    Simonsen U; Christensen FH; Buus NH
    Pharmacol Ther; 2009 May; 122(2):109-24. PubMed ID: 19268689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lercanidipine reduces matrix metalloproteinase-2 activity and reverses vascular dysfunction in renovascular hypertensive rats.
    Martinez ML; Castro MM; Rizzi E; Fernandes K; Demacq C; Bendhack LM; Gerlach RF; Tanus-Santos JE
    Eur J Pharmacol; 2008 Sep; 591(1-3):224-30. PubMed ID: 18634778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of vascular reactive oxygen species in development of vascular abnormalities in diabetes.
    Son SM
    Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S65-70. PubMed ID: 17467110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sympathoexcitation by oxidative stress in the brain mediates arterial pressure elevation in obesity-induced hypertension.
    Nagae A; Fujita M; Kawarazaki H; Matsui H; Ando K; Fujita T
    Circulation; 2009 Feb; 119(7):978-86. PubMed ID: 19204299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative stress in hypertension: association with antihypertensive treatment.
    Khanna HD; Sinha MK; Khanna S; Tandon R
    Indian J Physiol Pharmacol; 2008; 52(3):283-7. PubMed ID: 19552060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thiazide diuretics, endothelial function, and vascular oxidative stress.
    Zhou MS; Schulman IH; Jaimes EA; Raij L
    J Hypertens; 2008 Mar; 26(3):494-500. PubMed ID: 18300860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactive oxygen species and glucocorticoid-induced hypertension.
    Ong SL; Zhang Y; Whitworth JA
    Clin Exp Pharmacol Physiol; 2008 Apr; 35(4):477-82. PubMed ID: 18307745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of gender and sex hormones on vascular oxidative stress.
    Miller AA; De Silva TM; Jackman KA; Sobey CG
    Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):1037-43. PubMed ID: 17714091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospects for the use of antioxidant therapy in hypertension.
    Digiesi V; Lenuzza M; Digiesi G
    Ann Ital Med Int; 2001; 16(2):93-100. PubMed ID: 11688366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative stress in prehypertension: rationale for antioxidant clinical trials.
    Nambiar S; Viswanathan S; Zachariah B; Hanumanthappa N; Magadi SG
    Angiology; 2009; 60(2):221-34. PubMed ID: 18796443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The molecular sources of reactive oxygen species in hypertension.
    Puddu P; Puddu GM; Cravero E; Rosati M; Muscari A
    Blood Press; 2008; 17(2):70-7. PubMed ID: 18568695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How does endothelin induce vascular oxidative stress in mineralocorticoid hypertension?
    Pollock DM
    Clin Sci (Lond); 2006 Feb; 110(2):205-6. PubMed ID: 16323976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative stress in vascular disease: causes, defense mechanisms and potential therapies.
    Förstermann U
    Nat Clin Pract Cardiovasc Med; 2008 Jun; 5(6):338-49. PubMed ID: 18461048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of reactive oxygen species in brainstem in neural mechanisms of hypertension.
    Hirooka Y
    Auton Neurosci; 2008 Nov; 142(1-2):20-4. PubMed ID: 18650132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.